Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 1636 AL 1650

Tailoring of P-glycoprotein for effective transportation of actives across blood-brain-barrier

Pathan N, Shende P.

J Control Release. 2021 Jul 10;335:398-407. doi: 10.1016/j.jconrel.2021.05.046. Epub 2021 Jun 2.

New strategies for fluorescently labeling proteins in the study of amyloids

Shimogawa M, Petersson EJ.

Curr Opin Chem Biol. 2021 Oct;64:57-66. doi: 10.1016/j.cbpa.2021.04.011. Epub 2021 Jun 3.

From Kuru to Alzheimer: A personal outlook

Brunori M.

Protein Sci. 2021 Sep;30(9):1776-1792. doi: 10.1002/pro.4145. Epub 2021 Jun 26.

Multitarget therapeutic approaches for Alzheimer's and Parkinson's diseases: an opportunity or an illusion?

Matos MJ.

Future Med Chem. 2021 Aug;13(15):1301-1309. doi: 10.4155/fmc-2021-0119. Epub 2021 Jun 17.

Communicating chronic hydrocephalus: A review

Roblot P, Mollier O, Ollivier M, Gallice T, Planchon C, Gimbert E, Danet M, Renault S, Auzou N, Laurens B, Jecko V.

Rev Med Interne. 2021 Nov;42(11):781-788. doi: 10.1016/j.revmed.2021.05.018. Epub 2021 Jun 16.

Induction of specific brain oscillations may restore neural circuits and be used for the treatment of Alzheimer's disease

Chan D, Suk HJ, Jackson B, Milman NP, Stark D, Beach SD, Tsai LH.

J Intern Med. 2021 Nov;290(5):993-1009. doi: 10.1111/joim.13329. Epub 2021 Jun 22.

Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines

Milane L, Dolare S, Jahan T, Amiji M.

Nanomedicine. 2021 Oct;37:102422. doi: 10.1016/j.nano.2021.102422. Epub 2021 Jun 25.

Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview

Lindberg MF, Meijer L.

Int J Mol Sci. 2021 Jun 3;22(11):6047. doi: 10.3390/ijms22116047.

The Relationship Between the Gut Microbiome and Neurodegenerative Diseases

Zhu X, Li B, Lou P, Dai T, Chen Y, Zhuge A, Yuan Y, Li L.

Neurosci Bull. 2021 Oct;37(10):1510-1522. doi: 10.1007/s12264-021-00730-8. Epub 2021 Jul 3.

Therapeutic potential of catalpol and geniposide in Alzheimer's and Parkinson's diseases: A snapshot of their underlying mechanisms

Zhang X, Liu K, Shi M, Xie L, Deng M, Chen H, Li X.

Brain Res Bull. 2021 Sep;174:281-295. doi: 10.1016/j.brainresbull.2021.06.020. Epub 2021 Jul 1.

The Role of the GABAergic System in Diseases of the Central Nervous System

Zhang W, Xiong BR, Zhang LQ, Huang X, Yuan X, Tian YK, Tian XB.

Neuroscience. 2021 Aug 21;470:88-99. doi: 10.1016/j.neuroscience.2021.06.037. Epub 2021 Jul 6.

TSPO imaging in animal models of brain diseases

Van Camp N, Lavisse S, Roost P, Gubinelli F, Hillmer A, Boutin H.

Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):77-109. doi: 10.1007/s00259-021-05379-z. Epub 2021 Jul 10.

Phosphodiesterase 7(PDE7): A unique drug target for central nervous system diseases

Chen Y, Wang H, Wang WZ, Wang D, Skaggs K, Zhang HT.

Neuropharmacology. 2021 Sep 15;196:108694. doi: 10.1016/j.neuropharm.2021.108694. Epub 2021 Jul 7.

Olfaction as an early marker of Parkinson's disease and Alzheimer's disease

Walker IM, Fullard ME, Morley JF, Duda JE.

Handb Clin Neurol. 2021;182:317-329. doi: 10.1016/B978-0-12-819973-2.00030-7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias